All In Biotech

Free tool

FAERS Monitor: Emtriva

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021896 or its brand name (Emtriva, Emtricitabine). Reports on generic versions are filed under their own applications.

Reports

7,211

Serious

6,881

95% of reports

Hospitalization

2,167

Death reported

901

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug interaction663
  • foetal exposure during pregnancy622
  • drug resistance437
  • anxiety432
  • virologic failure407
  • drug ineffective331
  • immune reconstitution inflammatory syndrome300
  • off label use279
  • pain264
  • emotional distress239
  • depression235
  • exposure during pregnancy229
  • pathogen resistance220
  • acute kidney injury213
  • renal failure205

Reports by year received

View as table
YearReports
200481
200595
2006115
2007123
2008154
2009198
2010129
2011141
2012118
2013240
2014245
2015390
2016568
2017582
2018646
2019686
2020709
2021496
2022510
2023396
2024261
2025207
2026121

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,948 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
virologic failureSignal407238.7216.488,869
immune reconstitution inflammatory syndromeSignal300186.8166.651,939
pathogen resistanceSignal22072.163.214,994
drug resistanceSignal43750.546.020,803
foetal exposure during pregnancySignal62222.520.812,699
drug interactionSignal66312.211.46,853
exposure during pregnancySignal22910.89.52,021
emotional distressSignal2395.85.1941
renal failureSignal2054.53.9559
anxietySignal4324.44.01,159
acute kidney injurySignal2134.13.6492
depressionSignal2353.02.7317
pain2641.31.114
off label use2790.90.81
drug ineffective3310.70.734

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.